On the origin of urinary renin: a translational approach LCW Roksnoer, BFJ Heijnen, D Nakano, J Peti-Peterdi, SB Walsh, ... Hypertension 67 (5), 927-933, 2016 | 58 | 2016 |
Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats LCW Roksnoer, R Van Veghel, R De Vries, IM Garrelds, UM Bhaggoe, ... Kidney International 88 (1), 109-120, 2015 | 52 | 2015 |
Blood pressure-independent renoprotection in diabetic rats treated with AT1 receptor–neprilysin inhibition compared with AT1 receptor blockade alone LCW Roksnoer, R van Veghel, MCC van Groningen, R de Vries, ... Clinical Science 130 (14), 1209-1220, 2016 | 47 | 2016 |
Angiotensin–neprilysin inhibition confers renoprotection in rats with diabetes and hypertension by limiting podocyte injury E Uijl, D C‘t Hart, LCW Roksnoer, MC Clahsen-van Groningen, ... Journal of hypertension 38 (4), 755-764, 2020 | 38 | 2020 |
Urinary markers of intrarenal renin-angiotensin system activity in vivo LCW Roksnoer, K Verdonk, AH van den Meiracker, EJ Hoorn, R Zietse, ... Current hypertension reports 15, 81-88, 2013 | 37 | 2013 |
Branched-chain amino acid requirements for enterally fed term neonates in the first month of life F de Groof, L Huang, I van Vliet, GJ Voortman, H Schierbeek, ... The American journal of clinical nutrition 99 (1), 62-70, 2014 | 35 | 2014 |
Urinary renin-angiotensin markers in polycystic kidney disease M Salih, DM Bovée, LCW Roksnoer, NF Casteleijn, SJL Bakker, ... American journal of physiology-Renal physiology 313 (4), F874-F881, 2017 | 24 | 2017 |
The intrarenal renin–angiotensin system: does it exist? Implications from a recent study in renal angiotensin-converting enzyme knockout mice X Lu, LCW Roksnoer, AHJ Danser Nephrology Dialysis Transplantation 28 (12), 2977-2982, 2013 | 24 | 2013 |
From ARB to ARNI in cardiovascular control E Uijl, LCW Roksnoer, EJ Hoorn, AHJ Danser Current hypertension reports 18, 1-10, 2016 | 19 | 2016 |
Beneficial effects of combined AT1 receptor/neprilysin inhibition (ARNI) versus AT1 receptor blockade alone in the diabetic eye T Prasad, LCW Roksnoer, P Zhu, A Verma, Y Li, WW Batenburg, ... Investigative Ophthalmology & Visual Science 57 (15), 6722-6730, 2016 | 14 | 2016 |
Effect of sodium bicarbonate supplementation on the renin-angiotensin system in patients with chronic kidney disease and acidosis: a randomized clinical trial DM Bovée, LCW Roksnoer, C van Kooten, JI Rotmans, L Vogt, ... Journal of nephrology, 1-9, 2020 | 13 | 2020 |
Methodologic issues in the measurement of urinary renin LCW Roksnoer, K Verdonk, IM Garrelds, EJ Hoorn, AHJ Danser cJASN 9, 2014 | 10 | 2014 |
Effects of direct renin blockade on renal & systemic hemodynamics and on RAAS activity, in weight excess and hypertension: a randomized clinical trial AJ Kwakernaak, LC Roksnoer, HJ Lambers Heerspink, ... Plos one 12 (1), e0169258, 2017 | 9 | 2017 |
Neprilysin inhibition and endothelin-1 elevation: Focus on the kidney LCW Roksnoer, E Uijl, R de Vries, IM Garrelds, AHJ Danser European Journal of Pharmacology 824, 128-132, 2018 | 6 | 2018 |
[OP. 5A. 07] IMPROVED RENAL HEMODYNAMICS REDUCE ALBUMINURIA AND RENAL MACROPHAGE INFILTRATION IN DIABETIC RATS TREATED WITH DUAL ANGIOTENSIN RECEPTOR AND NEPRILYSIN INHIBITION E Uijl, LCW Roksnoer, MCG Van, JA Joles, EJ Hoorn, AHJ Danser Journal of Hypertension 35, e42, 2017 | | 2017 |
The Renin-Angiotensin System in Hypertension and Diabetes L Roksnoer | | 2016 |
The Renin-Angiotensin system in Hypertension and Diabetes: from man to rodent and back L Roksnoer | | 2016 |
Beneficial effects of combined AT1 receptor/neprilysin inhibition (ARNI) versus AT1 receptor blockade alone in the diabetic eye Q Li, L Roksnoer, T Prasad, P Zhu, A Verma, W Batenburg, R de Vries, ... Investigative Ophthalmology & Visual Science 57 (12), 2712-2712, 2016 | | 2016 |
Dual AT1 Receptor/Neprlysin Inhibition (ARNI) BS. AT1 Receptor Blockade in Diabetic TGR (mREN2) 27 Rats J Danser, LCW Roksnoer, WW Batenburg JOURNAL OF VASCULAR RESEARCH 53, 3-3, 2016 | | 2016 |
PP. 14.07: DUAL AT1 RECEPTOR/NEPRILYSIN INHIBITION (ARNI) VS. AT1 RECEPTOR BLOCKADE IN DIABETIC TGR (MREN2) 27 RATS L Roksnoer, R Van Veghel, R De Vries, IM Garrelds, UM Bhaggoe, ... Journal of Hypertension 33, e247-e248, 2015 | | 2015 |